Effect of early surgery in high surgical risk geriatric patients with femoral neck fracture and taking antiplatelet agents

12Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.

Abstract

AIM: To investigate the effect of early surgical intervention on the high surgical risk elderly patients who sustained femoral neck fracture (FNF) and taking concomitant antiplatelet agents. METHODS: Between 2010 and 2012, a prospective study was conducted on 49 geriatric patients, who took antiplatelet agents, sustained FNF and underwent surgery within 72 h [early surgery (ES) group], and these were compared with a retrospective consecutive case series of patients with similar characteristics (45 cases) who had delayed surgery (DS group) after 72 h during an earlier 3-year period. Postoperative outcomes were followed for one year and compared. RESULTS: There were non-significant differences in perioperative blood loss, blood transfusion, intensive care unit requirement and postoperative mortality (P > 0.05 all). There were 2 patients (4%) in the DS group who died after surgery (P = 0.23). However, the ES group showed a significantly better postoperative outcome in terms of postoperative complications, length of hospital stay, and functional outcome (P < 0.05 all). CONCLUSION: Early hip surgery in geriatric hip fracture patients with ongoing antiplatelet treatment was not associated with a significant increase of perioperative blood loss and postoperative mortality. Moreover, ES resulted in a better postoperative surgical outcome. In early hip surgery protocol, the antiplatelet agents are discontinued and the patient is operated on within 72 h after admission, which is safe and effective for the medically fit patients.

Cite

CITATION STYLE

APA

Sa-ngasoongsong, P., Kulachote, N., Sirisreetreerux, N., Chanplakorn, P., Laohajaroensombat, S., Pinsiranon, N., … Wajanavisit, W. (2015). Effect of early surgery in high surgical risk geriatric patients with femoral neck fracture and taking antiplatelet agents. World Journal of Orthopedics, 6(11), 970–976. https://doi.org/10.5312/wjo.v6.i11.970

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free